Having high insulin levels may be more than tough to manage when you have diabetes: New research shows it also appears to raise the risk of pancreatic cancer. In the study, scientists found excessive insulin levels overstimulated pancreatic acinar cells, which produce digestive juices. This overstimulation triggers inflammation that turns these cells into precancerous cells.… read on > read on >
All Health and Wellness:
How Much Vision Loss Impairs Your Driving? New Study Has Answers
A Mr. Magoo with thick glasses peering out from behind the wheel might not inspire confidence from his fellow motorists, but a new study shows other types of vision loss might be even more dangerous while driving. Loss of peripheral vision also can dramatically increase the risk of a car crash, Australian researchers presented in… read on > read on >
Man Maimed by Electric Shock Receives First-Ever Face Transplant That Includes New Eye
KEY TAKEAWAYS: An Arkansas man has received the world’s first whole-eye transplant, along with a partial face transplant The man suffered horrific injuries in 2021 when his face touched a live wire His surgery took 21 hours and a medical team of more than 140 surgeons, nurses and other health care professionals An Arkansas man… read on > read on >
Majority of Workers at America’s Nursing Homes Unvaccinated Against Flu, COVID
Health care workers at America’s nursing homes are woefully under-vaccinated for both flu and COVID-19, threatening their own health and that of the frail elderly patients under their care, a new report finds. Looking at 2023 data collected at nearly 14,000 nursing homes nationwide, researchers found that that fewer than one in every four (22.9%)… read on > read on >
People’s Heart Health Improves in More ‘Flexible’ Workplaces
A kinder, more thoughtful workplace can lead to better heart health among older employees, a new study finds. Older workers’ heart health risk factors decreased significantly when their office employed interventions designed to reduce work-family conflicts, researchers report in the Nov. 8 issue of the American Journal of Public Health. Specifically, their heart risk factors… read on > read on >
Income, Education Can Affect Your Stroke Recovery
Strokes can strike anyone, but income and education may play a role in whether your stroke is fatal or disabling, new research shows. As reported Nov. 8 in the journal Neurology, folks who’d had a stroke were 10% more likely to die or become dependent on someone for their care if they were low-income or… read on > read on >
Wegovy, Ozempic Probably Won’t Harm Vision in People With Diabetes, Study Finds
THURSDAY, Nov. 9, 2023 (HealthDay) — There’s good news for people with diabetes who are turning to drugs like Ozempic and Wegovy to treat their disease and lose weight: The drugs probably will not harm their vision. Semaglutide (the generic name for both medicines) can trigger rapid drops in blood sugar. Prior research had linked… read on > read on >
Eczema Takes Big Toll on Mental Health, Survey Finds
Eczema can be a burden on the mind as well the body, a new survey shows. People with eczema are more likely to experience depression and anxiety, and it worsens when additional allergic symptoms occur, according to a study to be presented Thursday at the American College of Allergy, Asthma and Immunology (ACAAI) annual meeting… read on > read on >
FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro
A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active ingredient, tirzepatide, as the diabetes drug Mounjaro. Both medications are made by Eli Lilly and Co. “Obesity and overweight are serious conditions that… read on > read on >
New Postpartum Depression Drug Comes With Hefty Price Tag
WEDNESDAY, Nov. 8, 2023 (Healthday News) — A new drug to treat postpartum depression will cost nearly $16,000 for a 14-day course of treatment, a price tag that has doctors worried that some patients won’t be able to afford the medication. Zurzuvae (zuranolone) was first approved by the U.S. Food and Drug Administration back in August,… read on > read on >